|
|
|
|||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
First published online 8 November 2006
doi: 10.1242/dev.02664
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Center for Aging and Developmental Biology, University of Rochester,
Rochester, NY 14642, USA.
2 Department of Biology, University of Victoria, Victoria, BC V8W 3N5,
Canada.
3 Department of Ophthalmology, University of Rochester, Rochester, NY 14642,
USA.
4 Department of Neurobiology and Anatomy, University of Rochester, Rochester, NY
14642, USA.
* Author for correspondence (e-mail: lin_gan{at}urmc.rochester.edu)
Accepted 28 September 2006
| SUMMARY |
|---|
|
|
|---|
Key words: Bhlhb5 (Beta3), bHLH, Math5 (Atoh7), NeuroD (Neurod1), Math3 (Neurod4), Amacrine cell, Bipolar cell, Retina, Neurogenesis, Transcription factors, Mouse
| INTRODUCTION |
|---|
|
|
|---|
Transcription factors play important roles in retinal cell fate
determination and genetic manipulation of these factors often leads to a loss
or an alteration of one or more cell fates in the retina
(Cepko, 1999
;
Marquardt, 2003
;
Marquardt and Gruss, 2002
).
Bipolar cell fate specification is dependent on the combined action of the
homeodomain protein Chx10 and the bHLH factors Mash1 and Math3 (Ascl1 and
Neurod4, respectively - both Mouse Genome Informatics)
(Burmeister et al., 1996
;
Hatakeyama et al., 2001
).
Chx10-null or Mash1-Math3 double-null mice exhibit a
complete loss of bipolar cells (Burmeister
et al., 1996
; Hatakeyama et
al., 2001
). Studies of Mash1-Math3 double-null retinas
also show that Mash1 and Math3 function redundantly to regulate bipolar cell
genesis and that loss of the two genes leads to an absence of bipolar cells
(Hatakeyama et al., 2001
).
Gain-of-function studies demonstrate that misexpression of Chx10, Mash1 or
Math3 alone does not promote bipolar cell genesis. By contrast, ectopic
expression of Mash1 or Math3 together with Chx10 increases the population of
mature bipolar cells. Thus, it is hypothesized that whereas Chx10 provides the
INL-specific identity, Mash1 and Math3 determine bipolar cell fate
(Hatakeyama et al., 2001
).
Recently, targeted deletion studies have revealed that Vsx1, a
paired- like homeodomain factor, and Bhlhb4, an Olig family bHLH
factor, are required for the development of the CB and RB subtypes,
respectively. Mice lacking Vsx1 are able to generate CB cells. However, the
terminal differentiation of CB cells in Vsx1-null retina is
incomplete, indicating that Vsx1 is required solely for the late
differentiation of OFF-CB cells (Chow et
al., 2004
; Ohtoshi et al.,
2004
). Similarly, Bhlhb4 plays no role in the initial generation
of bipolar cells, and loss of Bhlhb4 prevents nascent RB cells from maturating
and eventually results in their apoptosis
(Bramblett et al., 2004
).
The expression of Math3, NeuroD (Neurod1 - Mouse Genome
Informatics) and Pax6 is associated with differentiating amacrine
cells as well as other retinal cells
(Jones et al., 1998
;
Morrow et al., 1999
;
Nishina et al., 1999
).
Mutation of NeuroD, Pax6 or Math3 alone does not impair the
differentiation of amacrine cells. Conditional deletion of Pax6 in
retina results in the formation of only amacrine cells
(Marquardt et al., 2001
).
Although the development of amacrine cells is unaffected in mice lacking
either NeuroD or Math3, mice deficient for both Math3 and
NeuroD are devoid of amacrine cells
(Inoue et al., 2002
). Cell
lineage analysis studies have demonstrated that retinal progenitors of the
Math3 and NeuroD double-null mice fail to differentiate into
amacrine cells. Instead of undergoing programmed cell death, these progenitors
transdifferentiate into ganglion and Müller glial cells
(Inoue et al., 2002
).
Misexpression of Math3 or NeuroD alone in developing retina
does not promote the differentiation of amacrine cells, but results in the
formation of rod cells (Inoue et al.,
2002
). Recently, it has been shown that the winged helix/forkhead
transcription factor Foxn4 plays an essential role in the formation of
amacrine and horizontal cells (Li et al.,
2004
). Loss of Foxn4 function leads to the complete
absence of horizontal cells and to a reduction in amacrine cells.
Interestingly, the expression of NeuroD and Math3 are
reduced in Foxn4-null retina, suggesting that Foxn4 acts
upstream of NeuroD and Math3 in the amacrine differentiation
pathway. The above genetic studies reveal the roles of these transcription
factors as pan-amacrine-determining factors. However, the transcription
factors responsible for retinal subtype specification remain elusive.
Bhlhb5 is a member of the Olig subfamily of bHLH transcription factors. It
has previously been shown to be expressed in a restricted manner in the
developing central nervous system (CNS), sensory organs, kidney and hair
follicles (Bramblett et al.,
2002
; Brunelli et al.,
2003
; Kim et al.,
2002
; McLellan et al.,
2002
; Peyton et al.,
1996
). Due to its inability to bind DNA alone or in combination
with other bHLH proteins, Bhlhb5 is thought to function as a negative
regulator of other bHLH proteins (Peyton
et al., 1996
). In vitro evidence has shown that Bhlhb5 represses
Pax6 promoter activity through a non-DNA-binding mechanism
(Xu et al., 2002
). However,
the role of Bhlhb5 in embryonic development remains unknown. In this report,
we demonstrate that Bhlhb5 is predominantly expressed in post-mitotic cells in
the developing mouse retina. Co-localization of Bhlhb5 and retinal cell
type-specific markers reveals that Bhlhb5 expression is restricted to
selective GABAergic amacrine and Type 2 OFF-CB cells. Targeted deletion of
Bhlhb5 leads to a loss of Type 2 OFF-CB and selective GABAergic
amacrine cells, implying that Bhlhb5 is indispensable for the
formation of these cells. Expression studies of early embryonic retinas have
demonstrated that Bhlhb5 is mostly expressed in cells of the
NeuroD+ and Math5+ lineage, and that the increased
formation of displaced amacrine cells in Math5-null retina is
associated with a substantial increase in cells expressing Bhlhb5 and NeuroD.
Furthermore, whereas loss of Bhlhb5 has no effect on the expression of
NeuroD, and Math5, Mash1 and Ngn1 (Atoh7,
Ascl1 and Neurog2, respectively - all Mouse Genome Informatics),
Math3 or Chx10, it does lead to the reduced generation of
GABAergic amacrine and OFF-CB subtypes. These studies strongly argue for the
crucial role of Bhlhb5 as a factor downstream of the bHLH-class of retinogenic
factors in the specification of amacrine and bipolar subtypes.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Histochemistry, immunohistochemistry, in situ hybridization, BrdU labeling and X-Gal staining
Staged mouse embryos were dissected and fixed in 4% paraformaldehyde/PBS
(PFA) at 4°C for 1-2 hours. The samples were then embedded and frozen in
OCT medium (Tissue-Tek) and sectioned at 14 µm. BrdU pulse-labeling and
Hematoxylin and Eosin staining were performed as described
(Pan et al., 2005
).
ß-Galactosidase activity was determined by X-Gal staining as previously
described (Gan et al., 1999
).
For in situ hybridization experiments, 20 µm cryosections were used as
previously described (Li and Joyner,
2001
). The working dilutions and sources of antibodies used in
this study were: goat anti-Bhlhb5 (1:1000, Santa Cruz), mouse
anti-bromodeoxyuridine (BrdU) (1:50, Developmental Studies Hybridoma Bank),
mouse anti-Brn3a (1:100, Santa Cruz), goat anti-Brn3b (1:2000, Santa Cruz),
mouse anti-calbindin (1:5000, Sigma), rabbit anticalretinin (1:2000,
Oncogene), rabbit anti-activated caspase-3 (1:200, BD Pharmingen), anti-ChAT
(choline acetyltransferase, 1:200, Chemicon), sheep anti-Chx10 (1:200,
Exalpha), rabbit anti-cyclin D3 (1:200, Santa Cruz), mouse anti-GAD65
(glutamate decarboxylase 65 kD, 1:200, BD Biosciences), mouse
anti-ß-galactosidase (LacZ) (1:500, DSHB), rabbit anti-LacZ (1:500,
Chemicon), mouse anti-Isl1/2 (1:400, DSHB), goat anti-NeuroD (1:500, E-17,
Santa Cruz), rabbit anti-NK3R (1:200) (Chow
et al., 2001
), rabbit anti-parvalbulmin (1:200, Sigma), rabbit
anti-phosphorylated histone H3 (1:400, Santa Cruz), and mouse anti-Pax6
(1:200, DSHB), rabbit anti-PKC
(1:5000, Sigma), rabbit anti-Prox1
(1:1000, Covance), rabbit anti-recoverin (1:200)
(Chow et al., 2001
), mouse
anti-syntaxin (1:5000, Sigma), rabbit anti-TH (tyrosine hydroxylase, 1:200,
Chemicon), rabbit anti-Vsx1 (1:100) (Chow
et al., 2001
). Alexa-conjugated secondary antibodies (Molecular
Probes) were used at a dilution of 1:1000. Images were captured with a Zeiss
Axioplan microscope. Whole-Mount immunostaining was performed as described
(Wang et al., 2001
), and was
scored using a confocal microscope. To quantify the number of different cell
type-specific markers on sections of retina, three or more age-matched retinas
were analyzed for each cell type. All data are presented as the
mean±s.d. Statistical analysis was performed using two-sample Student's
t test for unequal variances.
| RESULTS |
|---|
|
|
|---|
|
Restricted expression of Bhlhb5 in GABAergic amacrine and OFF-CB subtypes
We further determined the identities of Bhlhb5+ cells by
co-immunolabeling adult mouse retinas with anti-Bhlhb5 and cell type-specific
markers. Strongly anti-Bhlhb5-labeled cells were mostly detected in the ACL
and the GCL, and somewhat weakly labeled cells within the outer boundary of
the INL (Fig. 2A). Co-labeling
of Bhlhb5 with the pan-amacrine cell marker Pax6 demonstrated that all
Bhlhb5+ cells in the ACL and in the GCL were Pax6+
(Fig. 2A-C), implying their
amacrine identity. The absence of Brn3a (Pou4f1 - Mouse Genome Informatics)
and cyclin D3 expression in Bhllhb5+ cells further excluded their
identity as ganglion and Müller cells (see Fig. S1A-A'', I-I''
in the supplementary material). To further define the subtypes of
Bhlhb5+ amacrine cells, we double-labeled retinas with anti-Bhlhb5
and amacrine subtype-specific markers. Whereas none of the Bhlhb5+
amacrine cells expressed markers for cholinergic amacrine (Isl1 and ChAT) (see
Fig. S1B-B'', C-C'' in the supplementary material), dopaminergic
amacrine (TH) (see Fig. S1D-D'' in the supplementary material),
calretinin (Fig. S1E-E'' in the supplementary material), or AII amacrine
(parvalbumin) (see Fig. S1F-F'' in the supplementary material) subtypes,
a majority of Bhlhb5+ cells expressed the GABAergic marker GAD65
(Gad2 - Mouse Genome Informatics), indicating that the Bhlhb5+
amacrine cells were mostly of the GABAergic subtype
(Fig. 2D-F). In addition, the
Prox1+ displaced amacrine cells in the GCL were Bhlhb5+
(Fig. 2G-I, arrows). The
co-localization of Prox1+ and Bhlhb5+ cells in the outer
boundary of the INL implied their identities as bipolar or horizontal cells
(Fig. 2G-I, arrowheads).
Nevertheless, Bhlhb5 was not co-expressed with the horizontal cell marker
calbindin-28K (see Fig. S1H-H'' in the supplementary material).
Co-immunolabeling with anti-Bhlhb5 and an antibody to Chx10, a pan-bipolar
cell marker, demonstrated that Bhlhb5 was expressed in bipolar cells
(Fig. 2J-L, arrowheads).
Careful examination of the double-labeled bipolar cells revealed that Bhlhb5
was expressed in those bipolar cells with a lower level of Chx10 but not those
with a higher level of Chx10 (Fig.
2J-L inserts, asterisks). Additional labeling experiments showed
that Bhlhb5+ cells did not express the RB cell-specific marker,
PKC
(see Fig. S1G-G'' in the supplementary material). Rather, all
of these Bhlhb5+ bipolar cells were labeled with the CB-specific
marker Vsx1 and represented approximately one third (37%) of the
Vsx1+ CB cell population (Fig.
2M-O, arrowheads). As Vsx1 is expressed in 60-70% of all CB cells
(Chow et al., 2004
), Bhlhb5 is
expressed in approximately 21-25% of CB cells. Furthermore, whereas not all
recoverin+ Type 2 OFF-CB cells (red arrowheads) expressed Bhlhb5
(white arrowheads), all Bhlhb5+ CB cells were recoverin+
(Fig. 2P-R), confirming these
Bhlhb5+ bipolar cells as Type 2 OFF-CB cells. In conclusion, Bhlhb5
is expressed selectively in GABAergic amacrine and Type 2 OFF-CB cells in the
adult retina.
|
To determine the role of Bhlhb5 in retinogenesis, we first
examined the retinas by Hematoxylin and Eosin staining. Whereas no noticeable
change in the thickness and laminar organization was found in
Bhlhb5-null retinas during embryogenesis
(Fig. 3A-F,K), there was a
significant reduction in the thickness of the INL postnatally
(Fig. 3G-K). Given the
restriction of Bhlhb5 expression to selective amacrine and CB subtypes, the
decrease in the INL of Bhlhb5-null mice indicated a loss of these
interneuron subtypes. Therefore, we analyzed the changes in specific retinal
subtypes using subtype-specific markers at P21, a time when all retinal cells
are generated and mature in mice. Anti-Pax6 labeling revealed that the total
number of amacrine cells was reduced in the INL and the GCL
(Fig. 4A,G). Immunolabeling
studies demonstrated a loss of 44.2±6% GABAergic amacrine cells, a
significant reduction of TH+ amacrine cells, and the absence of
Prox1+ displaced amacrine cells, respectively
(Fig. 4B-D,H-J and see Fig. S3
in the supplementary material). Although the anti-ChAT immunolabeling was
somewhat weak in Bhlhb5-null retina
(Fig. 4E,K), the number of
ChAT+ cells was unchanged (Fig.
4M,S and see Fig. S3 in the supplementary material). Similarly, no
overt changes in the number of AII (Prox1+) and
calretinin+ amacrine subtypes were observed
(Fig. 4D,F,J,L, and see Fig. S3
in the supplementary material). Among the bipolar subtypes, the
Vsx1+ CB subtype was reduced by 36.3±7%
(Fig. 4N,T and see Fig. S3 in
the supplementary material) whereas the PKC
+ and
Go
+ bipolar cells (Fig.
4O,P,U,V) and the Brn3b+ and Brn3a+ RGCs
were unaffected (Fig.
4Q,R,W,X). Altogether, our results demonstrated that targeted
deletion of Bhlhb5 resulted in the reduction of specific retinal
subtypes, particularly the CB, GABAergic and displaced amacrine subtypes that
normally express Bhlhb5.
|
|
Upregulation of Bhlhb5 and NeuroD in math5-null retinas
Previous studies have indicated that NeuroD and Math3 play redundant roles
in the differentiation of amacrine cells
(Inoue et al., 2002
). To
determine the genetic relationship of Bhlhb5 and NeuroD in the amacrine
differentiation pathway, we investigated whether Bhlhb5 co-expressed with
NeuroD in developing retinas. Immunolabeling experiments demonstrated that
although both NeuroD- and Bhlhb5-expressing cells were similarly distributed
throughout the NBL of E13.5 retina, NeuroD was detected in a greater number of
cells than Bhlhb5 (Fig. 6A-D),
and virtually all Bhlhb5+ cells expressed NeuroD
(Fig. 6E,F). We then tested
whether the absence of Bhlhb5 could affect the expression of NeuroD and
Math3. As shown by anti-NeuroD labeling and in situ hybridization for
Math3, the expression of both NeuroD and Math3 was detected
mostly in the NBL of developing retinas and was unaltered in
Bhlhb5-null retinas (Fig.
6G,H,L,M). Similarly, the expression of other retinogenic factors
such as Math5, Ngn2 and Mash1 was unaffected by the targeted deletion of
Bhlhb5 (Fig.
6I,K,N-P). Therefore, it is unlikely that Bhlhb5 functions
upstream of these retinogenic factors during retinal neurogenesis. Rather, it
could act downstream of these factors to control the differentiation of
retinal subtypes.
|
| DISCUSSION |
|---|
|
|
|---|
|
|
Similarly, whereas NeuroD and Math3 are essential for the generation of amacrine cells, our studies have shown that Bhlhb5 is expressed only in selective GABAergic and displaced amacrine subtypes, and that targeted deletion of Bhlhb5 leads to a specific reduction in these amacrine subtypes (Fig. 4 and see Fig. S3 in the supplementary material). During early retinogenesis, Bhlhb5 expression in the NBL is mostly confined to cells that express NeuroD and loss of Bhlhb5 does not alter the retinal expression of NeuroD and Math3 (Fig. 6), suggesting that Bhlhb5 is unlikely to function upstream of NeuroD and Math3 in retinogenesis. Although further studies are needed to test whether Bhlhb5 is downstream of NeuroD and Math3 and, in particular, whether its expression in retina is reduced in mice deficient for NeuroD and Math3, it is plausible that Bhlhb5 is expressed in a subset of NeuroD+ cells after they acquire a pan-amacrine identity to render these cells a GABAergic amacrine subtype identity.
During retinal development, all retinal cell types are generated from the
same pool of multipotent progenitors. The bHLH-class retinogenic factors have
been shown to play crucial roles in regulating the cell fate choices of
progenitors and loss of these factors frequently results in cell fate
phenotypes. Math3 and NeuroD double-null retinas lack amacrine cells but gain
more RGCs and Müller cells (Inoue et
al., 2002
). Loss of both Mash1 and Math3 leads to a cell fate
switch from bipolar to Müller cells
(Tomita et al., 2000
). In this
study, the loss of Type 2 OFF-CB and selective GABAergic amacrine cells in
Bhlhb5-null retinas was not accompanied by an overt increase in other
retinal cell types (Fig. 4).
One explanation for the lack of a readily identifiable cell fate switch is
that the amacrine and CB subtypes affected in Bhlhb5- null retinas
only represent a small population of retinal cells and that any consequent
cell fate change would be less obvious. Additionally, analysis of cell
proliferation during retinogenesis revealed a slight decrease in the number of
proliferating cells in postnatal Bhlhb5-null retinas (see Fig. S4E-J
in the supplementary material). It is possible that the reduced cell
proliferation could also contribute to the loss of late-born cells in the INL
of Bhlhb5-null retinas. To detect a possible cell fate change, Cre
recombinase could be used to replace the Bhlhb5 allele. Cell lineage
analysis using Bhlhb5Cre knock-in and lineage-reporter
mice could be used to trace the fates of Bhlhb5-expressing cells. Comparison
of the retinal cell fates of Bhlhb5+ lineage in the presence and
absence of Bhlhb5 would accurately reveal whether Bhlhb5 is exclusively
expressed in selective OFF-CB and GABAergic amacrine lineages, and whether
Bhlhb5-expressing cells switch fates in the absence of Bhlhb5. Our results
have also shown that the Bhlhb5-null mutation leads to a reduction in
TH+ dopaminergic amacrine cells
(Fig. 4). It is possible that
such a reduction results, as a non-cell-autonomous mechanism of
Bhlhb5, from the loss of other amacrine and bipolar subtypes.
Alternatively, the loss could be through a cell-autonomous mechanism as
Bhlhb5 could be transiently expressed in the dopaminergic amacrine
cell lineage and be essential for their development. Due to the lack of
embryonic and early postnatal markers for dopaminergic amacrine cells, we are
unable to distinguish these two possibilities in this study. Future cell
lineage analysis with Bhlhb5Cre knock-in mice could
effectively show whether Bhlhb5 is expressed in dopaminergic amacrine
lineage.
|
Supplementary material
Supplementary material for this article is available at
http://dev.biologists.org/cgi/content/full/133/24/4815/DC1
| ACKNOWLEDGMENTS |
|---|
| REFERENCES |
|---|
|
|
|---|
Bramblett, D. E., Copeland, N. G., Jenkins, N. A. and Tsai, M. J. (2002). BHLHB4 is a bHLH transcriptional regulator in pancreas and brain that marks the dimesencephalic boundary. Genomics 79,402 -412.[CrossRef][Medline]
Bramblett, D. E., Pennesi, M. E., Wu, S. M. and Tsai, M. J. (2004). The transcription factor Bhlhb4 is required for rod bipolar cell maturation. Neuron 43,779 -793.[CrossRef][Medline]
Brown, N. L., Kanekar, S., Vetter, M. L., Tucker, P. K., Gemza, D. L. and Glaser, T. (1998). Math5 encodes a murine basic helix-loop-helix transcription factor expressed during early stages of retinal neurogenesis. Development 125,4821 -4833.[Abstract]
Brunelli, S., Innocenzi, A. and Cossu, G. (2003). Bhlhb5 is expressed in the CNS and sensory organs during mouse embryonic development. Gene Expr. Patterns 3, 755-759.[CrossRef][Medline]
Burmeister, M., Novak, J., Liang, M. Y., Basu, S., Ploder, L., Hawes, N. L., Vidgen, D., Hoover, F., Goldman, D., Kalnins, V. I. et al. (1996). Ocular retardation mouse caused by Chx10 homeobox null allele: impaired retinal progenitor proliferation and bipolar cell differentiation. Nat. Genet. 12,376 -384.[CrossRef][Medline]
Cepko, C. L. (1999). The roles of intrinsic and extrinsic cues and bHLH genes in the determination of retinal cell fates. Curr. Opin. Neurobiol. 9, 37-46.[CrossRef][Medline]
Cheng, C. W., Chow, R. L., Lebel, M., Sakuma, R., Cheung, H. O., Thanabalasingham, V., Zhang, X., Bruneau, B. G., Birch, D. G., Hui, C. C. et al. (2005). The Iroquois homeobox gene, Irx5, is required for retinal cone bipolar cell development. Dev. Biol. 287, 48-60.[CrossRef][Medline]
Chow, R. L., Snow, B., Novak, J., Looser, J., Freund, C., Vidgen, D., Ploder, L. and McInnes, R. R. (2001). Vsx1, a rapidly evolving paired-like homeobox gene expressed in cone bipolar cells. Mech. Dev. 109,315 -322.[CrossRef][Medline]
Chow, R. L., Volgyi, B., Szilard, R. K., Ng, D., McKerlie, C.,
Bloomfield, S. A., Birch, D. G. and McInnes, R. R. (2004).
Control of late off-center cone bipolar cell differentiation and visual
signaling by the homeobox gene Vsx1. Proc. Natl. Acad. Sci.
USA 101,1754
-1759.
DeVries, S. H. and Baylor, D. A. (1995). An
alternative pathway for signal flow from rod photoreceptors to ganglion cells
in mammalian retina. Proc. Natl. Acad. Sci. USA
92,10658
-10662.
Gan, L., Xiang, M., Zhou, L., Wagner, D. S., Klein, W. H. and
Nathans, J. (1996). POU domain factor Brn-3b is required for
the development of a large set of retinal ganglion cells. Proc.
Natl. Acad. Sci. USA 93,3920
-3925.
Gan, L., Wang, S. W., Huang, Z. and Klein, W. H. (1999). POU domain factor Brn-3b is essential for retinal ganglion cell differentiation and survival but not for initial cell fate specification. Dev. Biol. 210,469 -480.[CrossRef][Medline]
Ghosh, K. K., Bujan, S., Haverkamp, S., Feigenspan, A. and Wassle, H. (2004). Types of bipolar cells in the mouse retina. J. Comp. Neurol. 469, 70-82.[CrossRef][Medline]
Hack, I., Peichl, L. and Brandstatter, J. H.
(1999). An alternative pathway for rod signals in the rodent
retina: rod photoreceptors, cone bipolar cells, and the localization of
glutamate receptors. Proc. Natl. Acad. Sci. USA
96,14130
-14135.
Hatakeyama, J., Tomita, K., Inoue, T. and Kageyama, R. (2001). Roles of homeobox and bHLH genes in specification of a retinal cell type. Development 128,1313 -1322.[Abstract]
Inoue, T., Hojo, M., Bessho, Y., Tano, Y., Lee, J. E. and Kageyama, R. (2002). Math3 and NeuroD regulate amacrine cell fate specification in the retina. Development 129,831 -842.[Medline]
Jones, S. E., Jomary, C., Grist, J., Thomas, M. R. and Neal, M. J. (1998). Expression of Pax-6 mRNA in the retinal degeneration (rd) mouse. Biochem. Biophys. Res. Commun. 252,236 -240.[CrossRef][Medline]
Kay, J. N., Finger-Baier, K. C., Roeser, T., Staub, W. and Baier, H. (2001). Retinal ganglion cell genesis requires lakritz, a zebrafish atonal Homolog. Neuron 30,725 -736.[CrossRef][Medline]
Kim, M. H., Gunnersen, J., Augustine, C. and Tan, S. S. (2002). Region-specific expression of the helix-loop-helix gene BETA3 in developing and adult brains. Mech. Dev. 114,125 -128.[CrossRef][Medline]
Li, J. Y. and Joyner, A. L. (2001). Otx2 and Gbx2 are required for refinement and not induction of mid-hindbrain gene expression. Development 128,4979 -4991.[Medline]
Li, S., Mo, Z., Yang, X., Price, S. M., Shen, M. M. and Xiang, M. (2004). Foxn4 controls the genesis of amacrine and horizontal cells by retinal progenitors. Neuron 43,795 -807.[CrossRef][Medline]
Marquardt, T. (2003). Transcriptional control of neuronal diversification in the retina. Prog. Retin. Eye Res. 22,567 -577.[CrossRef][Medline]
Marquardt, T. and Gruss, P. (2002). Generating neuronal diversity in the retina: one for nearly all. Trends Neurosci. 25,32 -38.[CrossRef][Medline]
Marquardt, T., Ashery-Padan, R., Andrejewski, N., Scardigli, R., Guillemot, F. and Gruss, P. (2001). Pax6 is required for the multipotent state of retinal progenitor cells. Cell 105, 43-55.[CrossRef][Medline]
Masland, R. H. (2001a). The fundamental plan of the retina. Nat. Neurosci. 4, 877-886.[CrossRef][Medline]
Masland, R. H. (2001b). Neuronal diversity in the retina. Curr. Opin. Neurobiol. 11,431 -436.[CrossRef][Medline]
McLellan, A. S., Langlands, K. and Kealey, T. (2002). Exhaustive identification of human class II basic helix-loop-helix proteins by virtual library screening. Gene Expr. Patterns 2,329 -335.[CrossRef][Medline]
Morrow, E. M., Furukawa, T., Lee, J. E. and Cepko, C. L. (1999). NeuroD regulates multiple functions in the developing neural retina in rodent. Development 126, 23-36.[Abstract]
Mu, X., Fu, X., Sun, H., Beremand, P. D., Thomas, T. L. and Klein, W. H. (2005). A gene network downstream of transcription factor Math5 regulates retinal progenitor cell competence and ganglion cell fate. Dev. Biol. 280,467 -481.[CrossRef][Medline]
Nishina, S., Kohsaka, S., Yamaguchi, Y., Handa, H., Kawakami,
A., Fujisawa, H. and Azuma, N. (1999). PAX6 expression in the
developing human eye. Br. J. Ophthalmol.
83,723
-727.
Ohtoshi, A., Wang, S. W., Maeda, H., Saszik, S. M., Frishman, L. J., Klein, W. H. and Behringer, R. R. (2004). Regulation of retinal cone bipolar cell differentiation and photopic vision by the CVC homeobox gene Vsx1. Curr. Biol. 14,530 -536.[CrossRef][Medline]
Pan, L., Yang, Z., Feng, L. and Gan, L. (2005).
Functional equivalence of Brn3 POU-domain transcription factors in mouse
retinal neurogenesis. Development
132,703
-712.
Peyton, M., Stellrecht, C. M., Naya, F. J., Huang, H. P., Samora, P. J. and Tsai, M. J. (1996). BETA3, a novel helix-loop-helix protein, can act as a negative regulator of BETA2 and MyoD-responsive genes. Mol. Cell. Biol. 16,626 -633.[Abstract]
Tomita, K., Moriyoshi, K., Nakanishi, S., Guillemot, F. and Kageyama, R. (2000). Mammalian achaete-scute and atonal homologs regulate neuronal versus glial fate determination in the central nervous system. EMBO J. 19,5460 -5472.[CrossRef][Medline]
Wang, S. W., Kim, B. S., Ding, K., Wang, H., Sun, D., Johnson,
R. L., Klein, W. H. and Gan, L. (2001). Requirement for math5
in the development of retinal ganglion cells. Genes
Dev. 15,24
-29.
Xu, Z. P., Dutra, A., Stellrecht, C. M., Wu, C., Piatigorsky, J. and Saunders, G. F. (2002). Functional and structural characterization of the human gene BHLHB5, encoding a basic helix-loop-helix transcription factor. Genomics 80,311 -318.[CrossRef][Medline]
Yang, Z., Ding, K., Pan, L., Deng, M. and Gan, L. (2003). Math5 determines the competence state of retinal ganglion cell progenitors. Dev. Biol. 264,240 -254.[CrossRef][Medline]
This article has been cited by other articles:
![]() |
L. Pan, M. Deng, X. Xie, and L. Gan ISL1 and BRN3B co-regulate the differentiation of murine retinal ganglion cells Development, June 1, 2008; 135(11): 1981 - 1990. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Gray Transcription factors and the genetic organization of brain stem respiratory neurons J Appl Physiol, May 1, 2008; 104(5): 1513 - 1521. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Qiu, H. Jiang, and M. Xiang A Comprehensive Negative Regulatory Program Controlled by Brn3b to Ensure Ganglion Cell Specification from Multipotential Retinal Precursors J. Neurosci., March 26, 2008; 28(13): 3392 - 3403. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Kerschensteiner, H. Liu, C. W. Cheng, J. Demas, S. H. Cheng, C.-c. Hui, R. L. Chow, and R. O. L. Wong Genetic Control of Circuit Function: Vsx1 and Irx5 Transcription Factors Regulate Contrast Adaptation in the Mouse Retina J. Neurosci., March 5, 2008; 28(10): 2342 - 2352. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Elshatory, D. Everhart, M. Deng, X. Xie, R. B. Barlow, and L. Gan Islet-1 Controls the Differentiation of Retinal Bipolar and Cholinergic Amacrine Cells J. Neurosci., November 14, 2007; 27(46): 12707 - 12720. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||